Commission awards its 50th EID grant to research into eradicating cancer blood supply
The 50th European Industrial Doctorate (EID) research grant has been awarded today by the European Commission. The €1.5 million grant is for research into new antibodies that will destroy a tumour’s blood vessels and eradicate the tumour. The project is led by the University of Birmingham in the UK and SomantiX, a Dutch biotech company based in Utrecht. The research is supported by associated European universities, companies and research centres.
Androulla Vassiliou, Commissioner for Education, Culture, Multilingualism and Youth, said: ” The EID is an excellent illustration of the added value that EU investment can bring for excellence, innovation and competitiveness by building bridges between academia, research and business.”
The EID was launched as a pilot project in 2012 as part of the Marie Curie Actions and aims to provide PhD candidates with professional experience in excellent research projects, as well as to attract more young people into scientific careers.
For more information: http://europa.eu/rapid/press-release_IP-13-784_en.htm